Detection of the Finnish-type congenital nephrotic syndrome by restriction fragment length polymorphism and dual-color oligonucleotide ligation assays

Clinical Chemistry

Volumn 46, Issue 6, 2000, Pages 811-816

  Romppanen, Eeva Liisa ^a,b   Mononen, Ilkka ^a,c  

^a KUOPIO UNIVERSITY HOSPITAL   (Finland)

^b UNIVERSITY OF EASTERN FINLAND   (Finland)

^c TURKU UNIVERSITY HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; AUTOSOMAL RECESSIVE DISORDER; BLOOD SAMPLING; CONGENITAL NEPHROTIC SYNDROME; DNA TEMPLATE; HUMAN; HUMAN CELL; NONSENSE MUTATION; OLIGONUCLEOTIDE PROBE; POLYMERASE CHAIN REACTION; PROTEINURIA; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SCREENING;

EID: 0034125964     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinchem/46.6.811     Document Type: Article

References (15)

1. 1. Huttunen N-P. Congenital nephrotic syndrome of Finnish type. Arch Dis Child 1976;51:344-8.
2. 2. Hallman N, Norio R, Kouvalainen K. Main features of the congenital nephrotic syndrome. Acta Paediatr Scand 1967;(Suppl 172): 75-8.
3. 3. Holmberg C, Antikainen M, Rönnholm K, Ala-Houhala M, Jalanko H. Management of congenital nephrotic syndrome of the Finnish type. Pediatr Nephrol 1995;9:87-93.
4. 4. Seppälä M, Rapola J, Huttunen N-P, Aula P, Karjalainen O, Ruoslahti E. Congenital nephrotic syndrome: prenatal diagnosis and genetic counselling by estimation of amniotic-fluid and maternal serum α-fetoprotein. Lancet 1976;II:123-5.
5. 5. Heinonen S, Ryynänen M, Kirkinen P, Penttilä I, Syrjänen K, Seppälä M, Saarikoski S. Prenatal screening for congenital nephrosis in east Finland: results and impact on the birth prevalence of the disease. Prenat Diagn 1996;16:207-13.
6. 6. Kestilä M, Lenkkeri U, Männikkö M, Lamerdin J, McCready P, Putaala H, et al. Positionally cloned gene for a novel glomerular protein-nephrin-is mutated in congenital nephrotic syndrome. Mol Cell 1998;1:575-82.
7. 7. Landegren U, Kaiser R, Sanders J, Hood L. A ligase-mediated gene detection technique. Science 1988;241:1077-80.
8. 8. Nickerson DA, Kaiser R, Lappin S, Stewart J, Hood L, Landegren U. Automated DNA diagnostics using an ELISA-based oligonucleotide ligation assay. Proc Natl Acad Sci U S A 1990;87:8923-7.
9. 9. Lenkkeri U, Männikkö M, McCready P, Lamerdin J, Gribouval O, Niaudet P, et al. Structure of the gene for congenital nephrotic syndrome of the Finnish type (NPHS1) and characterization of mutations. Am J Hum Genet 1999;64:51-61.
10. 10. Nollau P, Wagener C. Methods for detection of point mutations: performance and quality assessment. Clin Chem 1997;43:1114-28.
11. 11. Tobe VO, Taylor SL, Nickerson DA. Single-well genotyping of diallelic sequence variations by a two-color ELISA-based oligonucleotide ligation assay. Nucleic Acids Res 1996;24:3728-32.
12. 12. Edelstein RE, Nickerson DA, Tobe VO, Manns-Arcuino LA, Frenkel LM. Oligonucleotide ligation assay for detecting mutations in the human immunodeficiency virus type 1 pol gene that are associated with resistance to zidovudine, didanosine, and lamivudine. J Clin Microbiol 1998;36:569-72.
13. 13. Delahunty CM, Ankener W, Brainerd S, Nickerson DA, Mononen IT. Finnish-type aspartylglucosaminuria detected by oligonucleotide ligation assay. Clin Chem 1995;41:59-61.
14. 14. Romppanen E-L, Mononen I. Carrier detection in aspartylglycosaminuria. In: Mononen I, Aronson NN, eds. Lysosomal storage disease: aspartylglycosaminuria. Austin, TX: R.G. Landes, 1997: 153-64.
15. 15. Romppanen E-L, Valtonen P, Mononen T, Mononen I. Molecular diagnosis of Finnish type infantile neuronal ceroid lipofuscinosis by restriction fragment length polymorphism and oligonucleotide ligation assay [Technical Brief]. Clin Chem 1998;44:2373-6.